Ruggaard & Associates LLC Drug Manufacturers—General

Ruggaard & Associates LLC

  • $216 Billion
  • Q2 2024

Stock List

Stock Option Type Value Options Held Last Trade Trade History
Filter Shares Options
Track This Portfolio

Track Ruggaard & Associates LLC Portfolio

Follow Ruggaard & Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ruggaard & Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ruggaard & Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email